Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-24 @ 4:35 PM
NCT ID:
NCT01767766
Eligibility Criteria:
Inclusion Criteria:
* Refractory to or relapsed after at least 1 prior treatment regimen;
* Eastern Cooperative Oncology Group (ECOG) score of 0 to 2;
* At least 18 years of age.
Exclusion Criteria:
* Any major surgery, chemotherapy or immunotherapy within the last 21 days (limited palliative radiation is allowed ≥ 2 weeks);
* Autologous hematologic stem cell transplant within 3 months of study entry or Allogeneic hematologic stem cell transplant within 12 months;
* Known hepatitis B virus, hepatitis C virus or HIV infection;
* Previous therapy with GS-1101 (CAL-101), IPI-145 or any drug that specifically inhibits the PI3K or mTOR pathway;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01767766
Study Brief:
Protocol Section:
NCT01767766